Constellation Pharmaceuticals

Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
Type
Private
HQ
Cambridge, US
Founded
2008
Employees
57 (est)+2%

Key People at Constellation Pharmaceuticals

Brenda Sousa

Brenda Sousa

Vice President of Human Resources
Matthias Jaffe

Matthias Jaffe

Chief Financial Officer
Mark A. Goldsmith

Mark A. Goldsmith

Executive Chairman
Cameron Wheeler

Cameron Wheeler

business development and operating experience
Keith Dionne

Keith Dionne

President & Chief Executive Officer
James Audia

James Audia

Chief Scientific Officer

Constellation Pharmaceuticals Locations

Cambridge, US

Constellation Pharmaceuticals Metrics

Constellation Pharmaceuticals Summary

Founding Date

2008

Total Funding

$210 M

Latest funding size

$55 M

Time since last funding

12 months

Investors

Constellation Pharmaceuticals News

Constellation Pharmaceuticals Company Life

You may also be interested in